Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.620
-0.210 (-4.35%)
Nov 17, 2026, 4:00 PM EST - Market closed

Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of $522.55 million. The enterprise value is $1.35 billion.

Market Cap522.55M
Enterprise Value 1.35B

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Evolent Health has 113.11 million shares outstanding. The number of shares has decreased by -2.43% in one year.

Current Share Class 113.11M
Shares Outstanding 113.11M
Shares Change (YoY) -2.43%
Shares Change (QoQ) +0.47%
Owned by Insiders (%) 1.95%
Owned by Institutions (%) 91.86%
Float 110.91M

Valuation Ratios

PE Ratio n/a
Forward PE 11.09
PS Ratio 0.22
Forward PS 0.16
PB Ratio 1.40
P/TBV Ratio n/a
P/FCF Ratio 14.82
P/OCF Ratio 8.05
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.05, with an EV/FCF ratio of 38.21.

EV / Earnings n/a
EV / Sales 0.58
EV / EBITDA 24.05
EV / EBIT n/a
EV / FCF 38.21

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 2.61.

Current Ratio 1.26
Quick Ratio 1.21
Debt / Equity 2.61
Debt / EBITDA 16.67
Debt / FCF 27.60
Interest Coverage -0.44

Financial Efficiency

Return on equity (ROE) is -83.57% and return on invested capital (ROIC) is -2.51%.

Return on Equity (ROE) -83.57%
Return on Assets (ROA) -0.86%
Return on Invested Capital (ROIC) -2.51%
Return on Capital Employed (ROCE) -2.07%
Weighted Average Cost of Capital (WACC) 7.13%
Revenue Per Employee $557,822
Profits Per Employee -$120,879
Employee Count4,200
Asset Turnover 1.06
Inventory Turnover n/a

Taxes

In the past 12 months, Evolent Health has paid $3.07 million in taxes.

Income Tax 3.07M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +10.53% in the last 52 weeks. The beta is 1.02, so Evolent Health's price volatility has been similar to the market average.

Beta (5Y) 1.02
52-Week Price Change +10.53%
50-Day Moving Average 4.24
200-Day Moving Average 3.93
Relative Strength Index (RSI) 51.50
Average Volume (20 Days) 1,699,596

Short Selling Information

The latest short interest is 10.61 million, so 9.38% of the outstanding shares have been sold short.

Short Interest 10.61M
Short Previous Month 12.91M
Short % of Shares Out 9.38%
Short % of Float 9.56%
Short Ratio (days to cover) 5.85

Income Statement

In the last 12 months, Evolent Health had revenue of $2.34 billion and -$507.69 million in losses. Loss per share was -$4.52.

Revenue2.34B
Gross Profit 350.28M
Operating Income -30.53M
Pretax Income -504.63M
Net Income -507.69M
EBITDA 56.02M
EBIT -30.53M
Loss Per Share -$4.52
Full Income Statement

Balance Sheet

The company has $148.26 million in cash and $973.05 million in debt, with a net cash position of -$824.80 million or -$7.29 per share.

Cash & Cash Equivalents 148.26M
Total Debt 973.05M
Net Cash -824.80M
Net Cash Per Share -$7.29
Equity (Book Value) 372.85M
Book Value Per Share 3.30
Working Capital 127.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $64.88 million and capital expenditures -$29.62 million, giving a free cash flow of $35.26 million.

Operating Cash Flow 64.88M
Capital Expenditures -29.62M
Depreciation & Amortization 86.55M
Net Borrowing -105.42M
Free Cash Flow 35.26M
FCF Per Share $0.31
Full Cash Flow Statement

Margins

Gross margin is 14.95%, with operating and profit margins of -1.30% and -21.67%.

Gross Margin 14.95%
Operating Margin -1.30%
Pretax Margin -21.54%
Profit Margin -21.67%
EBITDA Margin 2.39%
EBIT Margin -1.30%
FCF Margin 1.50%

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 2.43%
Shareholder Yield 2.43%
Earnings Yield -97.87%
FCF Yield 6.75%

Analyst Forecast

The average price target for Evolent Health is $6.00, which is 29.87% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 29.87%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (3Y) 25.66%
EPS Growth Forecast (3Y) 80.18%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evolent Health has an Altman Z-Score of 0.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.41
Piotroski F-Score 4